[Seasonal and Perennial Allergic Rhinoconjunctivitis]

Area of Science:

• Ophthalmology
• Allergology
• Immunology

Background:

• Seasonal allergic conjunctivitis (SAC) and perennial allergic conjunctivitis (PAC) are common, often co-occurring with allergic rhinitis, collectively termed allergic rhinoconjunctivitis.
• These conditions, predominantly IgE-mediated hypersensitivity reactions to aeroallergens, significantly impact patient quality of life, necessitating effective management strategies.
• While acute forms like SAC and PAC are milder than chronic ones, their high prevalence underscores their clinical and socioeconomic relevance.

Purpose of the Study:

• To review the clinical presentation, pathophysiology, and management of allergic rhinoconjunctivitis.
• To highlight the importance of accurate diagnosis for targeted and effective treatment.
• To emphasize treatment options that improve patient quality of life.

Main Methods:

• Literature review of allergic rhinoconjunctivitis, covering epidemiology, etiology, clinical findings, and therapeutic approaches.
• Analysis of current treatment guidelines and pharmacological options for ocular and nasal allergy symptoms.
• Discussion of the benefits of combination therapies and long-term management strategies.

Main Results:

• Allergic rhinoconjunctivitis is characterized by ocular symptoms like itching, conjunctival injection, and watery discharge, alongside nasal symptoms such as rhinorrhea and sneezing.
• Management includes allergen avoidance, artificial tears for mild cases, and pharmacotherapy with topical antihistamines, mast cell stabilizers, or dual-action drugs.
• Topical steroids should be used cautiously, with a preference for unpreserved eye drops for prolonged treatment. Combination therapies with nasal steroids show a good safety profile.

Conclusions:

• Allergic rhinoconjunctivitis is a prevalent condition with significant impact on quality of life.
• Effective and targeted treatment, based on accurate diagnosis, can rapidly improve patient symptoms and well-being.
• A range of therapeutic options, including combination therapies, offers safe and effective management for allergic rhinoconjunctivitis.